Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Treatment of Patients With Immune Thrombocytopenic Purpura: The ITP^2 Study

NCT00991939 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.

NCT NCT00991939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00991939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Treatment of Patients With Immune Thrombocytopenic Purpura: The ITP^2 Study
Lead sponsor
Carelon Research
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2010
Completion date
March 31, 2013
Enrollment
8 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenic purpura